Forbes 30 Under 30 Europe: Powerful Medical Founders Join 2024 Class
Our co-founders, Martin Herman and Robert Herman, MD, have been recognized as part of the prestigious Forbes 30 Under 30 Europe 2024 list for their exceptional work in reshaping cardiovascular care.
In a world where medical technology advances at an unprecedented pace, it’s the visionaries and innovators who lead the way in transforming healthcare. This year, we are honored to share that our co-founders, Martin Herman and Robert Herman, MD, have been recognized as part of the prestigious Forbes 30 Under 30 Europe 2024 list for their exceptional work in reshaping cardiovascular care.
Selected from thousands of nominations, Martin and Robert’s inclusion in this list is a reflection of their dedication to revolutionizing cardiac diagnostics through artificial intelligence. At Powerful Medical, we are committed to the early detection and timely management of acute heart attacks and 38 other heart conditions, a mission that has the potential to improve and save countless lives of cardiac patients.
Combining cutting-edge AI with deep medical expertise, we aim to provide healthcare professionals with innovative diagnostic tools. Our AI-powered certified ECG interpretation platform, PMcardio, enables quicker and more accurate detection of heart attacks, facilitating timely intervention that can significantly improve patient outcomes.
Joining a global community of young entrepreneurs and change-makers, Martin and Robert are now part of a network of individuals dedicated to making a lasting impact.
To compile the Forbes Europe 30 Under 30 ninth annual list, Forbes’ team delved into thousands of submissions online and sought recommendations from industry insiders and previous listees. The Forbes team, alongside an independent panel of judges, including notable figures like Renzo Rosso, Simona Tabasco, and Mo Farah, evaluated candidates based on factors such as funding, revenue, social impact, scale, creativity, and future potential.
“We could not have reached this milestone without the hard work and dedication of our entire team. Every day, their expertise and passion help bring our vision closer to reality. Our journey is also supported by our investors and partners, whose faith in our mission has been invaluable,” said Martin Herman, CEO of Powerful Medical. “Celebrating this achievement, we also extend our congratulations to everyone recognized in this year’s Forbes 30 Under 30 list. These individuals serve as an inspiration to us and, undoubtedly, to the generations that will follow.”
“As we continue our journey to enter new markets, integrate PMcardio into more healthcare institutions, accumulate more clinical evidence, and develop new AI models for conditions like heart failure, the recognition by Forbes inspires us to further innovate cardiovascular care, aiming to make a meaningful impact on patient lives worldwide.”, adds Dr. Robert Herman, Chief Medical Officer at Powerful Medical.
Share this article
About PMcardio
PMcardio is a CE-marked Class IIb AI medical device that interprets any 12-lead ECG — from a photo or a digital file — in seconds. It detects 50+ ECG findings, including occlusion myocardial infarction (OMI) — the acute coronary occlusions that conventional STEMI criteria miss in over half of cases. Its Queen of Hearts™ OMI model holds FDA Breakthrough Device Designation, and PMcardio is already used by 100,000+ clinicians who have analyzed more than 2.5 million ECGs.
About Powerful Medical
Powerful Medical is a medical-technology company using artificial intelligence to transform how cardiovascular disease — the world’s leading cause of death — is diagnosed. Founded in 2017, it built PMcardio, the world’s first AI medical device to detect acute coronary occlusion (OMI) from an ECG. Its research is published in the European Heart Journal – Digital Health and validated across 25+ clinical studies, and its Queen of Hearts™ model earned FDA Breakthrough Device Designation. To date, PMcardio has supported the detection of 120,000+ heart attacks across 150+ hospital deployments worldwide.
